BPC-157

A stable 15–amino-acid sequence pulled from a protein found in human gastric juice. In rodents it seems to speed healing by recruiting new blood vessels and driving soft-tissue repair, and by keeping tendon and gut cells alive and migrating where they are needed. Exactly how it pulls this off is still being worked out — and none of it has been confirmed in humans.

There is a lot of BPC-157 literature. Read the fine print, though: it is overwhelmingly preclinical, and a striking share of it traces back to a single research group. Hundreds of rodent studies report faster healing of tendon, muscle, ligament, bone, and gut tissue, including protection against NSAID-induced gut damage. Published human randomized trials? As of this writing, none. That absence is the whole story — strong rodent signals are not a promise of human benefit, and the lack of any long-term human safety data is a limitation, not a footnote.

• Faster tendon and ligament healing in rat injury models
• Quicker muscle and bone repair after experimental injury (animal)
• Gut protection and healing in rodent models of ulcer and inflammatory bowel disease
• Reversal of NSAID-induced gut damage in animals

• No published human RCTs — efficacy in people is unproven
• No long-term human safety data; effects of chronic dosing are unknown
• Sold "for research use only," so purity, dose accuracy, and contamination vary by source
• Theoretical concern that pro-angiogenic activity could be undesirable in people with cancer
• Not approved by the FDA for any human use

Research compound. Sold "for research use only" — not approved for human consumption.

Goals studied: Tendon & ligament repair, Gut healing, Muscle recovery

Is BPC-157 proven to work in humans?

No. The evidence base is overwhelmingly animal studies. There are no published randomized controlled trials in humans, so human efficacy is unproven.

Is BPC-157 legal?

In the US it is sold only as a "research compound," not approved for human use. In 2023 the FDA flagged it for removal from the list of bulk substances compounding pharmacies may use. It is also banned in sport by WADA.

How is BPC-157 taken in studies?

Animal studies use both injection and oral administration. Because there are no human dosing trials, any human "protocol" circulating online is extrapolated from rodent data, not established.

1. [1]
   Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing

   Gwyer D, Wragg NM, Wilson SL · Cell and Tissue Research · 2019 · PMID 30915550 · model: animal

   Revue de la littérature préclinique concluant que le BPC-157 accélère la réparation des tendons, ligaments et muscles dans divers modèles de lésion.

2. [2]
   The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

   Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JHS · Journal of Applied Physiology · 2011 · PMID 21030672 · model: in-vitro

   Étude cellulaire reliant le BPC-157 à la croissance, la survie et la migration des ténocytes via la voie FAK-paxilline.

3. [3]
   Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing

   Sikiric P, et al. · Current Pharmaceutical Design · 2018 · PMID 29879879 · model: animal

   Revue situant les effets gastro-protecteurs et vasculaires du BPC-157 dans les modèles précliniques autour de l'angiogenèse.